9 results on '"Caiazzo A. L."'
Search Results
2. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- Author
-
Bouzbid, S, Hamdi-Chérif, M, Zaidi, Z, Meguenni, K, Regagba, D, Bayo, S, Cheick Bougadari, T, Manraj, S S, Bendahhou, K, Fabowale, A, Bradshaw, D, Somdyala, N I M, Kumcher, I, Moreno, F, Calabrano, G H, Espinola, S B, Carballo Quintero, B, Fita, R, Diumenjo, M C, Laspada, W D, Ibañez, S G, Lima, C A, De Souza, P C F, Del Pino, K, Laporte, C, Curado, M P, de Oliveira, J C, Veneziano, C L A, Veneziano, D B, Latorre, M R D O, Tanaka, L F, Rebelo, M S, Santos, M O, Galaz, J C, Aparicio Aravena, M, Sanhueza Monsalve, J, Herrmann, D A, Vargas, S, Herrera, V M, Uribe, C J, Bravo, L E, Garcia, L S, Arias-Ortiz, N E, Morantes, D, Jurado, D M, Yépez Chamorro, M C, Delgado, S, Ramirez, M, Galán Alvarez, Y H, Torres, P, Martínez-Reyes, F, Jaramillo, L, Quinto, R, Castillo, J, Mendoza, M, Cueva, P, Yépez, J G, Bhakkan, B, Deloumeaux, J, Joachim, C, Macni, J, Carrillo, R, Shalkow Klincovstein, J, Rivera Gomez, R, Poquioma, E, Tortolero-Luna, G, Zavala, D, Alonso, R, Barrios, E, Eckstrand, A, Nikiforuk, C, Noonan, G, Turner, D, Kumar, E, Zhang, B, McCrate, F R, Ryan, S, MacIntyre, M, Saint-Jacques, N, Nishri, D E, McClure, C A, Vriends, K A, Kozie, S, Stuart-Panko, H, Freeman, T, George, J T, Brockhouse, J T, O'Brien, D K, Holt, A, Almon, L, Kwong, S, Morris, C, Rycroft, R, Mueller, L, Phillips, C E, Brown, H, Cromartie, B, Schwartz, A G, Vigneau, F, Levin, G M, Wohler, B, Bayakly, R, Ward, K C, Gomez, S L, McKinley, M, Cress, R, Green, M D, Miyagi, K, Ruppert, L P, Lynch, C F, Huang, B, Tucker, T C, Deapen, D, Liu, L, Hsieh, M C, Wu, X C, Schwenn, M, Gershman, S T, Knowlton, R C, Alverson, G, Copeland, G E, Bushhouse, S, Rogers, D B, Jackson-Thompson, J, Lemons, D, Zimmerman, H J, Hood, M, Roberts-Johnson, J, Rees, J R, Riddle, B, Pawlish, K S, Stroup, A, Key, C, Wiggins, C, Kahn, A R, Schymura, M J, Radhakrishnan, S, Rao, C, Giljahn, L K, Slocumb, R M, Espinoza, R E, Khan, F, Aird, K G, Beran, T, Rubertone, J J, Slack, S J, Garcia, L, Rousseau, D L, Janes, T A, Schwartz, S M, Bolick, S W, Hurley, D M, Whiteside, M A, Miller-Gianturco, P, Williams, M A, Herget, K, Sweeney, C, Johnson, A T, Keitheri Cheteri, M B, Migliore Santiago, P, Blankenship, S E, Farley, S, Borchers, R, Malicki, R, Espinoza, J R, Grandpre, J, Wilson, R, Edwards, B K, Mariotto, A, Lei, Y, Wang, N, Chen, J S, Zhou, Y, He, Y T, Song, G H, Gu, X P, Mei, D, Mu, H J, Ge, H M, Wu, T H, Li, Y Y, Zhao, D L, Jin, F, Zhang, J H, Zhu, F D, Junhua, Q, Yang, Y L, Jiang, C X, Biao, W, Wang, J, Li, Q L, Yi, H, Zhou, X, Dong, J, Li, W, Fu, F X, Liu, S Z, Chen, J G, Zhu, J, Li, Y H, Lu, Y Q, Fan, M, Huang, S Q, Guo, G P, Zhaolai, H, Wei, K, Zeng, H, Demetriou, A V, Mang, W K, Ngan, K C, Kataki, A C, Krishnatreya, M, Jayalekshmi, P A, Sebastian, P, Nandakumar, A, Malekzadeh, R, Roshandel, G, Keinan-Boker, L, Silverman, B G, Ito, H, Nakagawa, H, Sato, M, Tobori, F, Nakata, I, Teramoto, N, Hattori, M, Kaizaki, Y, Moki, F, Sugiyama, H, Utada, M, Nishimura, M, Yoshida, K, Kurosawa, K, Nemoto, Y, Narimatsu, H, Sakaguchi, M, Kanemura, S, Naito, M, Narisawa, R, Miyashiro, I, Nakata, K, Sato, S, Yoshii, M, Oki, I, Fukushima, N, Shibata, A, Iwasa, K, Ono, C, Nimri, O, Jung, K W, Won, Y J, Alawadhi, E, Elbasmi, A, Ab Manan, A, Adam, F, Sanjaajmats, E, Tudev, U, Ochir, C, Al Khater, A M, El Mistiri, M M, Teo, Y Y, Chiang, C J, Lee, W C, Buasom, R, Sangrajrang, S, Kamsa-ard, S, Wiangnon, S, Daoprasert, K, Pongnikorn, D, Leklob, A, Sangkitipaiboon, S, Geater, S L, Sriplung, H, Ceylan, O, Kög, I, Dirican, O, Köse, T, Gurbuz, T, Karaşahin, F E, Turhan, D, Aktaş, U, Halat, Y, Yakut, C I, Altinisik, M, Cavusoglu, Y, Türkköylü, A, Üçüncü, N, Hackl, M, Zborovskaya, A A, Aleinikova, O V, Henau, K, Van Eycken, L, Valerianova, Z, Yordanova, M R, Šekerija, M, Dušek, L, Zvolský, M, Storm, H, Innos, K, Mägi, M, Malila, N, Seppä, K, Jégu, J, Velten, M, Cornet, E, Troussard, X, Bouvier, A M, Guizard, A V, Bouvier, V, Launoy, G, Arveux, P, Maynadié, M, Mounier, M, Woronoff, A S, Daoulas, M, Robaszkiewicz, M, Clavel, J, Goujon, S, Lacour, B, Baldi, I, Pouchieu, C, Amadeo, B, Coureau, G, Orazio, S, Preux, P M, Rharbaoui, F, Marrer, E, Trétarre, B, Colonna, M, Delafosse, P, Ligier, K, Plouvier, S, Cowppli-Bony, A, Molinié, F, Bara, S, Ganry, O, Lapôtre-Ledoux, B, Grosclaude, P, Bossard, N, Uhry, Z, Bray, F, Piñeros, M, Stabenow, R, Wilsdorf-Köhler, H, Eberle, A, Luttmann, S, Löhden, I, Nennecke, A L, Kieschke, J, Sirri, E, Emrich, K, Zeissig, S R, Holleczek, B, Eisemann, N, Katalinic, A, Asquez, R A, Kumar, V, Petridou, E, Ólafsdóttir, E J, Tryggvadóttir, L, Clough-Gorr, K, Walsh, P M, Sundseth, H, Mazzoleni, G, Vittadello, F, Coviello, E, Cuccaro, F, Galasso, R, Sampietro, G, Giacomin, A, Magoni, M, Ardizzone, A, D'Argenzio, A, Castaing, M, Grosso, G, Lavecchia, A M, Sutera Sardo, A, Gola, G, Gatti, L, Ricci, P, Ferretti, S, Serraino, D, Zucchetto, A, Celesia, M V, Filiberti, R A, Pannozzo, F, Melcarne, A, Quarta, F, Russo, A G, Carrozzi, G, Cirilli, C, Cavalieri d'Oro, L, Rognoni, M, Fusco, M, Vitale, M F, Usala, M, Cusimano, R, Mazzucco, W, Michiara, M, Sgargi, P, Boschetti, L, Borciani, E, Seghini, P, Maule, M M, Merletti, F, Tumino, R, Mancuso, P, Vicentini, M, Cassetti, T, Sassatelli, R, Falcini, F, Giorgetti, S, Caiazzo, A L, Cavallo, R, Cesaraccio, R, Pirino, D R, Contrino, M L, Tisano, F, Fanetti, A C, Maspero, S, Carone, S, Mincuzzi, A, Candela, G, Scuderi, T, Gentilini, M A, Piffer, S, Rosso, S, Barchielli, A, Caldarella, A, Bianconi, F, Stracci, F, Contiero, P, Tagliabue, G, Rugge, M, Zorzi, M, Beggiato, S, Brustolin, A, Berrino, F, Gatta, G, Sant, M, Buzzoni, C, Mangone, L, Capocaccia, R, De Angelis, R, Zanetti, R, Maurina, A, Pildava, S, Lipunova, N, Vincerževskiené, I, Agius, D, Calleja, N, Siesling, S, Larønningen, S, Møller, B, Dyzmann-Sroka, A, Trojanowski, M, Góźdź, S, Mężyk, R, Mierzwa, T, Molong, L, Rachtan, J, Szewczyk, S, Błaszczyk, J, Kępska, K, Kościańska, B, Tarocińska, K, Zwierko, M, Drosik, K, Maksimowicz, K M, Purwin-Porowska, E, Reca, E, Wójcik-Tomaszewska, J, Tukiendorf, A, Grądalska-Lampart, M, Radziszewska, A U, Gos, A, Talerczyk, M, Wyborska, M, Didkowska, J A, Wojciechowska, U, Bielska-Lasota, M, Forjaz de Lacerda, G, Rego, R A, Bastos, J, Silva, M A, Antunes, L, Laranja Pontes, J, Mayer-da-Silva, A, Miranda, A, Blaga, L M, Coza, D, Gusenkova, L, Lazarevich, O, Prudnikova, O, Vjushkov, D M, Egorova, A G, Orlov, A E, Kudyakov, L A, Pikalova, L V, Adamcik, J, Safaei Diba, C, Primic-Žakelj, M, Zadnik, V, Larrañaga, N, Lopez de Munain, A, Herrera, A A, Redondas, R, Marcos-Gragera, R, Vilardell Gil, M L, Molina, E, Sánchez Perez, M J, Franch Sureda, P, Ramos Montserrat, M, Chirlaque, M D, Navarro, C, Ardanaz, E E, Guevara, M M, Fernández-Delgado, R, Peris-Bonet, R, Carulla, M, Galceran, J, Alberich, C, Vicente-Raneda, M, Khan, S, Pettersson, D, Dickman, P, Avelina, I, Staehelin, K, Camey, B, Bouchardy, C, Schaffar, R, Frick, H, Herrmann, C, Bulliard, J L, Maspoli-Conconi, M, Kuehni, C E, Redmond, S M, Bordoni, A, Ortelli, L, Chiolero, A, Konzelmann, I, Matthes, K L, Rohrmann, S, Broggio, J, Rashbass, J, Fitzpatrick, D, Gavin, A, Clark, D I, Deas, A J, Huws, D W, White, C, Montel, L, Rachet, B, Turculet, A D, Stephens, R, Chalker, E, Phung, H, Walton, R, You, H, Guthridge, S, Johnson, F, Gordon, P, D'Onise, K, Priest, K, Stokes, B C, Venn, A, Farrugia, H, Thursfield, V, Dowling, J, Currow, D, Hendrix, J, Lewis, C, Allemani, Claudia, Matsuda, Tomohiro, Di Carlo, Veronica, Harewood, Rhea, Matz, Melissa, Nikšić, Maja, Bonaventure, Audrey, Valkov, Mikhail, Johnson, Christopher J, Estève, Jacques, Ogunbiyi, Olufemi J, Azevedo e Silva, Gulnar, Chen, Wan-Qing, Eser, Sultan, Engholm, Gerda, Stiller, Charles A, Monnereau, Alain, Woods, Ryan R, Visser, Otto, Lim, Gek Hsiang, Aitken, Joanne, Weir, Hannah K, and Coleman, Michel P
- Published
- 2018
- Full Text
- View/download PDF
3. Changes in life expectancy for cancer patients over time since diagnosis
- Author
-
Botta, L., Dal Maso, L., Guzzinati, S., Panato, C., Gatta, G., Trama, A., Rugge, M., Tagliabue, G., Casella, C., Caruso, B., Michiara, M., Ferretti, S., Sensi, F., Tumino, R., Toffolutti, F., Russo, A. G., Caiazzo, A. L., Mangone, L., Mazzucco, W., Iacovacci, S., Ricci, P., Gola, G., Candela, G., Sardo, A. S., De Angelis, R., Buzzoni, C., Capocaccia, R., AIRTUM Working Group, Botta, Laura, Dal Maso, Luigino, Guzzinati, Stefano, Panato, Chiara, Gatta, Gemma, Trama, Annalisa, Rugge, Massimo, Tagliabue, Giovanna, Casella, Claudia, Caruso, Bianca, Michiara, Maria, Ferretti, Stefano, Sensi, Flavio, Tumino, Rosario, Toffolutti, Federica, Giampiero Russo, Antonio, Luisa Caiazzo, Anna, Mangone, Lucia, Mazzucco, Walter, Iacovacci, Silvia, Ricci, Paolo, Gola, Gemma, Candela, Giuseppa, Sutera Sardo, Antonella, De Angelis, Roberta, Buzzoni, Carlotta, and Capocaccia, Riccardo
- Subjects
0301 basic medicine ,Pediatrics ,medicine.medical_specialty ,cancer survivor ,Life expectancy ,Cancer survivors ,Population ,YLL, years of life lost ,(ICD-O-3), international classification of diseases for oncology, third revision ,Socio-culturale ,Life expectancy, Population-based cancer registry, Relative survival, Cancer, Cancer survivors, Italy ,Settore MED/42 - Igiene Generale E Applicata ,Relative survival ,03 medical and health sciences ,0302 clinical medicine ,Health care ,Medicine ,education ,lcsh:Science (General) ,Population-based cancer registry ,Thyroid cancer ,Cancer ,RS, relative survival ,education.field_of_study ,lcsh:R5-920 ,Multidisciplinary ,business.industry ,Absolute risk reduction ,medicine.disease ,LE, life expectancy ,NHL, non-Hodgkin lymphoma ,030104 developmental biology ,Years of potential life lost ,Italy ,ISTAT, national institute of statistics ,030220 oncology & carcinogenesis ,(ICD-10), international classification of diseases tenth revision ,Original Article ,business ,lcsh:Medicine (General) ,lcsh:Q1-390 - Abstract
Highlights • Research question: how cancer impacts on LE changes during patients’ entire life • LE increased in patients surviving the first years and decreasing thereafter. • Patients’ LE in the end approached but seldom reached the general population’s LE. • This method describes when cancer survivors’ excess risk of death became negligible. • Life expectancy indicator is easy to be understood and interpreted by patients., Graphical abstract, The aims of this study were to provide life expectancy (LE) estimates of cancer patients at diagnosis and LE changes over time since diagnosis to describe the impact of cancer during patients' entire lives. Cancer patients' LE was calculated by standard period life table methodology using the relative survival of Italian patients diagnosed in population-based cancer registries in 1985–2011 with follow-up to 2013. Data were smoothed using a polynomial model and years of life lost (YLL) were calculated as the difference between patients' LE and that of the age- and sex-matched general population. The YLL at diagnosis was highest at the youngest age at diagnosis, steadily decreasing thereafter. For patients diagnosed at age 45 years, the YLL was above 20 for lung and ovarian cancers and below 6 for thyroid cancer in women and melanoma in men. LE progressively increased in patients surviving the first years, decreasing thereafter, to approach that of the general population. YLL in the long run mainly depends on attained age. Providing quantitative data is essential to better define clinical follow-up and plan health care resource allocation. These results help assess when the excess risk of death from tumour becomes negligible in cancer survivors.
- Published
- 2019
4. Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates
- Author
-
Zorzi M., Zappa M., Mazzoleni G., Morrone G., Caputo E., Galasso R., Citarella A., Sampietro G., Magoni M., Cavalieri D'Oro L., Ardizzone A., D'Argenzio A., Sciacca S., Pisani S., Ricci P., Giorno A., Ferretti S., Palma F., Serraino D., Iacovacci S., Quarta F., Filiberti R. A., Vitarelli S., Russo A. G., Carrozzi G., D'Orsi G., Fusco M., Sini G. M., Vitale F., Michiara M., Boschetti L., Chiaranda G., Rosso S., Tumino R., Mangone L., Valenti Clemente S., Falcini F., Caiazzo A. L., Cesaraccio R., Madeddu A., Fanetti A. C., Minerba S., Caldarella A., Candela G., Piffer S., Stracci F., Tagliabue G., Rugge M., Brustolin A., Castelli M., Zorzi M., Zappa M., Mazzoleni G., Morrone G., Caputo E., Galasso R., Citarella A., Sampietro G., Magoni M., Cavalieri D'Oro L., Ardizzone A., D'Argenzio A., Sciacca S., Pisani S., Ricci P., Giorno A., Ferretti S., Palma F., Serraino D., Iacovacci S., Quarta F., Filiberti R.A., Vitarelli S., Russo A.G., Carrozzi G., D'Orsi G., Fusco M., Sini G.M., Vitale F., Michiara M., Boschetti L., Chiaranda G., Rosso S., Tumino R., Mangone L., Valenti Clemente S., Falcini F., Caiazzo A.L., Cesaraccio R., Madeddu A., Fanetti A.C., Minerba S., Caldarella A., Candela G., Piffer S., Stracci F., Tagliabue G., Rugge M., Brustolin A., and Castelli M.
- Subjects
Adenoma ,Male ,Colorectal cancer ,colorectal cancer ,Target population ,colorectal cancer screening ,NO ,Screening programme ,Single indicator ,medicine ,Humans ,Mass Screening ,National level ,Early Detection of Cancer ,Aged ,Potential impact ,business.industry ,Incidence ,Incidence (epidemiology) ,Gastroenterology ,Colonoscopy ,Colorectal Neoplasms ,Female ,Italy ,Middle Aged ,Occult Blood ,Patient Compliance ,Program Evaluation ,medicine.disease ,Colorectal cancer screening ,business ,Demography - Abstract
ObjectiveThe impact of a screening programme on colorectal cancer (CRC) incidence in its target population depends on several variables, including coverage with invitations, participation rate, positivity rate of the screening test, compliance with an invitation to second-level assessment and endoscopists’ sensitivity. We propose a synthetic indicator that may account for all the variables influencing the potential impact of a screening programme on CRC incidence.DesignWe defined the ‘rate of advanced adenoma on the target population’ (AA-TAP) as the rate of patients who received a diagnosis of advanced adenoma within a screening programme, divided by the programme target population. We computed the AA-TAP for the CRC Italian screening programmes (biennial faecal immunochemical test, target population 50–69 year olds) using the data of the Italian National Survey from 2003 to 2016, overall and by region, and assessed the association between AA-TAP and CRC incidence fitting a linear regression between the trend of regional CRC incidence rates in 50–74 year old subjects and the cumulative AA-TAP.ResultsIn 2016, the AA-TAP at a national level was 105×100 000, whereas significant differences were observed between the northern and central regions (respectively 126 and 149×100 000) and the South and Islands (36×100 000). The cumulative AA-TAP from 2004 to 2012 was significantly correlated with the difference between CRC incidence rates in 2013–2014 and those in 2003–2004 (p=0.009).ConclusionThe AA-TAP summarises into a single indicator the potential impact of a screening programme in reducing CRC incidence rates.
- Published
- 2019
- Full Text
- View/download PDF
5. Decline in the incidence of colorectal cancer and the associated mortality in young Italian adults
- Author
-
Zorzi M., Cavestro G. M., Guzzinati S., Dal Maso L., Rugge M., Mazzoleni G., Morrone G., Caputo E., Galasso R., Citarella A., Sampietro G., Magoni M., Cavalieri D'Oro L., Ardizzone A., D'Argenzio A., Sciacca S., Pisani S., Ricci P., Giorno A., Ferretti S., Palma F., Serraino D., Iacovacci S., Quarta F., Filiberti R. A., Vitarelli S., Russo A. G., Carrozzi G., D'Orsi G., Fusco M., Sini G. M., Vitale F., Michiara M., Boschetti L., Chiaranda G., Rosso S., Tumino R., Mangone L., Valenti Clemente S., Falcini F., Caiazzo A. L., Cesaraccio R., Madeddu A., Fanetti A. C., Minerba S., Caldarella A., Candela G., Piffer S., Stracci F., Tagliabue G., Tolin M., Brustolin A., Castelli M., Zorzi M., Cavestro G.M., Guzzinati S., Dal Maso L., Rugge M., Mazzoleni G., Morrone G., Caputo E., Galasso R., Citarella A., Sampietro G., Magoni M., Cavalieri D'Oro L., Ardizzone A., D'Argenzio A., Sciacca S., Pisani S., Ricci P., Giorno A., Ferretti S., Palma F., Serraino D., Iacovacci S., Quarta F., Filiberti R.A., Vitarelli S., Russo A.G., Carrozzi G., D'Orsi G., Fusco M., Sini G.M., Vitale F., Michiara M., Boschetti L., Chiaranda G., Rosso S., Tumino R., Mangone L., Valenti Clemente S., Falcini F., Caiazzo A.L., Cesaraccio R., Madeddu A., Fanetti A.C., Minerba S., Caldarella A., Candela G., Piffer S., Stracci F., Tagliabue G., Tolin M., Brustolin A., Castelli M., Zorzi, M., Cavestro, G. M., Guzzinati, S., Dal Maso, L., and Rugge, M
- Subjects
0301 basic medicine ,Colon ,Population ,Socio-culturale ,colorectal cancer ,colorectal cancer screening ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Epidemiology of cancer ,Medicine ,Humans ,Risk factor ,education ,education.field_of_study ,cancer epidemiology, Colorectal cancer, colorectal cancer screening ,business.industry ,Incidence (epidemiology) ,Mortality rate ,screening ,Incidence ,Gastroenterology ,Cancer ,medicine.disease ,Obesity ,Annual Percent Change ,Europe ,030104 developmental biology ,Italy ,030211 gastroenterology & hepatology ,epidemiology ,business ,Colorectal Neoplasms ,Demography ,cancer epidemiology ,SEER Program - Abstract
Objective The incidence of colorectal cancer (CRC) declines among subjects aged 50 years and above. An opposite trend appears among younger adults. In Europe, data on CRC incidence among younger adults are lacking. We therefore aimed to analyse European trends in CRC incidence and mortality in subjects younger than 50 years. Design Data on age-related CRC incidence and mortality between 1990 and 2016 were retrieved from national and regional cancer registries. Trends were analysed by Joinpoint regression and expressed as annual percent change. Results We retrieved data on 143.7 million people aged 20–49 years from 20 European countries. Of them, 187 918 (0.13%) were diagnosed with CRC. On average, CRC incidence increased with 7.9% per year among subjects aged 20–29 years from 2004 to 2016. The increase in the age group of 30–39 years was 4.9% per year from 2005 to 2016, the increase in the age group of 40–49 years was 1.6% per year from 2004 to 2016. This increase started earliest in subjects aged 20–29 years, and 10–20 years later in those aged 30–39 and 40–49 years. This is consistent with an age-cohort phenomenon. Although in most European countries the CRC incidence had risen, some heterogeneity was found between countries. CRC mortality did not significantly change among the youngest adults, but decreased with 1.1%per year between 1990 and 2016 and 2.4% per year between 1990 and 2009 among those aged 30–39 years and 40–49 years, respectively. Conclusion CRC incidence rises among young adults in Europe. The cause for this trend needs to be elucidated. Clinicians should be aware of this trend. If the trend continues, screening guidelines may need to be reconsidered.
- Published
- 2020
6. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study
- Author
-
Bielska-Lasota, M., Rossi, S., Krzyzak, M., Haelens, A., Domenic, A., De Angelis, R., Maciejczyk, A., Rodriguez-Barranco, M., Zadnik, V., Minicozzi, P., Hackl, M., Ihle, P., Vaneycken, E., Henau, K., Valerianova, Z., Dimitrova, N., Sekerija, M., Cukelj, P., Dusek, L., Zvolsky, M., Magi, M., Aareleid, T., Malila, N., Seppa, K., Velten, M., Guizard, A. V., Faivre, J., Woronoff, A. S., Tretarre, B., Bossard, N., Uhry, Z., Colonna, M., Molinie, F., Cowppli-Bony, A., Bara, S., Lapotre-Ledoux, B., Grosclaude, P., Stabenow, R., Luttmann, S., Eberle, A., Brenner, H., Nennecke, A., Engel, J., Schubert-Fritschle, G., Heidrich, J., Holleczek, B., Katalinic, A., Birgisson, H., Tryggvadottir, L., Clough-Gorr, K., Mazzoleni, G., Bulatko, A., Buzzoni, C., Suterasardo, A., Mancuso, P., Ferretti, S., Barchielli, A., Caldarella, A., Gatta, G., Sant, M., Amati, C., Baili, P., Berrino, F., Bonfarnuzzo, S., Botta, L., Capocaccia, R., Foschi, R., Margutti, C., Meneghini, E., Trama, A., Serraino, D., Dalmaso, L., Deangelis, R., Dibenedetto, C., Caldora, M., Francisci, S., Galati, F., Mallone, S., Pierannunzio, D., Tallon, M., Santaquilani, M., Tavilla, A., Pannozzo, F., Busco, S., Filiberti, R. A., Marani, E., Ricci, P., Spagnoli, G., Cirilli, C., Fusco, M., Vitale, M. F., Usala, M., Vitale, F., Mazzucco, W., Michiara, M., Zanetti, R., Rosso, S., Tumino, R., Mangone, L., Difelice, E., Russo, A. G., Andreano, A., Falcini, F., Caiazzo, A. L., Cesaraccio, R., Piffer, S., Madeddu, A., Tisano, F., Fanetti, A. C., Cometti, I., Candela, P., Scuderi, T., Stracci, F., Bianconi, F., Tagliabue, G., Contiero, P., Rugge, M., Zorzi, M., Pildava, S., Smailyte, G., Azzopardi, M., Calleja, N., Johannesen, T. B., Rachtan, J., Gozdz, S., Macek, P., Blaszczyk, J., Bebenek, M., Forjaz deLacerda, G., Bento, M. J., Antunes, L., Miranda, A., Mayer-da-Silva, A., Safaeidiba, C., Primic-Zakelj, M., Lopez deMunain, A., Gil, L., Diazgarcia, J. M., Marcos-Navarro, A. I., Marcos-Gragera, R., Puigdemont, M., Sanchez, M. J., Chang, D. Y. L., Chirlaque, M. D., Ardanaz, E., Guevara, M., Galceran, J., Carulla, M., Lambe, M., Khan, S., Staehelin, K., Bouchardy, C., Fournier, E., Mousavi, S. M., Ess, S. M., Lorez, M., Mousavi, M., Herrmann, C., Bordoni, A., Spitale, A., Konzelmann, I., Visser, O., Aarts, M., Otter, R., Coleman, M., Allemani, C., Rachet, B., Rashbass, J., Broggio, J., Verne, J., Gavin, A., Donnelly, D., Morrison, D., Black, R., Huws, D. W., Thomas, R., Bielska‑Lasota, M, Rossi, S, Krzyżak, M, Haelens, A, Domenic, A, De Angelis, R, Maciejczyk, A, Rodríguez‑Barranco, M, Zadnik, V, Minicozzi, P, Vitale, F, and Mazzucco, W
- Subjects
Morphology ,Adult ,Male ,Stage at diagnosi ,Survival ,Adolescent ,Socio-culturale ,Uterine Cervical Neoplasms ,Disease ,Settore MED/42 - Igiene Generale E Applicata ,03 medical and health sciences ,0302 clinical medicine ,Medicine ,media_common.cataloged_instance ,Humans ,European Union ,European union ,Survival rate ,Population-based study ,media_common ,Aged ,Retrospective Studies ,Cervical cancer ,Aged, 80 and over ,Cervical cancer, Europe, Morphology, Population-based study, Stage at diagnosis, Survival ,030219 obstetrics & reproductive medicine ,Relative survival ,business.industry ,Absolute risk reduction ,Obstetrics and Gynecology ,Retrospective cohort study ,Stage at diagnosis ,General Medicine ,Middle Aged ,medicine.disease ,Europe ,Eastern european ,Survival Rate ,030220 oncology & carcinogenesis ,Female ,business ,Demography - Abstract
Purpose: With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burden decreased in several European countries. In Eastern European (EE) countries, which accessed European Union in 2004, CC survival was worse than in the rest of Europe. The present study investigates CC survival differences across five European regions, considering stage at diagnosis (local, regional and metastatic), morphology (mainly squamous versus glandular tumours) and patients’ age. Methods: We analysed 101,714 CC women diagnosed in 2000–2007 and followed-up to December 2008. Age-standardised 5-year relative survival (RS) and the excess risks of cancer death in the 5years after diagnosis were computed. Results: EE women were older and less commonly diagnosed with glandular tumours. Proportions of local stage cancers were similar across Europe, while morphology- and stage-specific RS (especially for non-metastatic disease) were lower in Eastern Europe. Adjusting for age and morphology, excess risk of local stage CC death for EE patients remained higher than that for other European women. Conclusion: Stage, age and morphology alone do not explain worse survival in Eastern Europe: less effective care may play a role, probably partly due to fewer or inadequate resources being allocated to health care in this area, compared to the rest of Europe.
- Published
- 2019
7. Prognosis and cure of long-term cancer survivors: A population-based estimation
- Author
-
Dal Maso, L., Panato, C., Guzzinati, S., Serraino, D., Francisci, S., Botta, L., Capocaccia, R., Tavilla, A., Gigli, A., Crocetti, E., Rugge, M., Tagliabue, G., Filiberti, R. A., Carrozzi, G., Michiara, M., Ferretti, S., Cesaraccio, R., Tumino, R., Falcini, F., Stracci, F., Torrisi, A., Mazzoleni, G., Fusco, M., Rosso, S., Tisano, F., Fanetti, A. C., Sini, G. M., Buzzoni, C., De Angelis, R., Virdone, S., Gatta, G., Zorzi, M., Mallone, S., Toffolutti, F., Russo, A. G., Caiazzo, A. L., Mangone, L., Mazzucco, W., Pannozzo, F., Ricci, P., Gola, G., Candela, G., Sutera Sardo, A., Dal Maso L., Panato C., Guzzinati S., Serraino D., Francisci S., Botta L., Capocaccia R., Tavilla A., Gigli A., Crocetti E., Rugge M., Tagliabue G., Filiberti R.A., Carrozzi G., Michiara M., Ferretti S., Cesaraccio R., Tumino R., Falcini F., Stracci F., Torrisi A., Mazzoleni G., Fusco M., Rosso S., Tisano F., Fanetti A.C., Sini G.M., Buzzoni C., De Angelis R., Virdone S., Gatta G., Zorzi M., Mallone S., Toffolutti F., Russo A.G., Caiazzo A.L., Mangone L., Mazzucco W., Pannozzo F., Ricci P., Gola G., Candela G., and Sutera Sardo A.
- Subjects
0301 basic medicine ,Oncology ,Male ,Cancer Research ,Time Factors ,Settore MED/42 - Igiene Generale E Applicata ,0302 clinical medicine ,Cancer Survivors ,Prostate ,Neoplasms ,Thyroid cancer ,Original Research ,education.field_of_study ,Relative survival ,Mortality rate ,Middle Aged ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Prognosis ,population-based cancer registrie ,medicine.anatomical_structure ,Italy ,030220 oncology & carcinogenesis ,cancer cure, Italy, population-based cancer registries, prevalence, survival ,Female ,Cancer Prevention ,Adult ,medicine.medical_specialty ,population-based cancer registries ,Adolescent ,Population ,prevalence ,Socio-culturale ,lcsh:RC254-282 ,survival ,03 medical and health sciences ,Young Adult ,Life Expectancy ,Internal medicine ,medicine ,population‐based cancer registries ,Humans ,Radiology, Nuclear Medicine and imaging ,cancer cure ,education ,Aged ,Estimation ,business.industry ,Cancer ,Models, Theoretical ,medicine.disease ,030104 developmental biology ,Life expectancy ,business - Abstract
Background: Increasing evidence of cure for some neoplasms has emerged in recent years. The study aimed to estimate population-based indicators of cancer cure. Methods: Information on more than half a million cancer patients aged 15-74 years collected by population-based Italian cancer registries and mixture cure models were used to estimate the life expectancy of fatal tumors (LEFT), proportions of patients with similar death rates of the general population (cure fraction), and time to reach 5-year conditional relative survival (CRS) >90% or 95% (time to cure). Results: Between 1990 and 2000, the median LEFT increased >1 year for breast (from 8.1 to 9.4 years) and prostate cancers (from 5.2 to 7.4 years). Median LEFT in 1990 was >5 years for testicular cancers (5.8) and Hodgkin lymphoma (6.3) below 45 years of age. In both sexes, it was 95% was 90% was reached in 15 years. Conclusions: The study findings confirmed that several cancer types are curable. The awareness of the possibility of cancer cure has relevant clinical and social impacts. KEYWORDS cancer cure, Italy, population-based cancer registries, prevalence, survival
- Published
- 2019
- Full Text
- View/download PDF
8. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- Author
-
Allemani, Claudia, primary, Matsuda, Tomohiro, additional, Di Carlo, Veronica, additional, Harewood, Rhea, additional, Matz, Melissa, additional, Nikšić, Maja, additional, Bonaventure, Audrey, additional, Valkov, Mikhail, additional, Johnson, Christopher J, additional, Estève, Jacques, additional, Ogunbiyi, Olufemi J, additional, Azevedo e Silva, Gulnar, additional, Chen, Wan-Qing, additional, Eser, Sultan, additional, Engholm, Gerda, additional, Stiller, Charles A, additional, Monnereau, Alain, additional, Woods, Ryan R, additional, Visser, Otto, additional, Lim, Gek Hsiang, additional, Aitken, Joanne, additional, Weir, Hannah K, additional, Coleman, Michel P, additional, Bouzbid, S, additional, Hamdi-Chérif, M, additional, Zaidi, Z, additional, Meguenni, K, additional, Regagba, D, additional, Bayo, S, additional, Cheick Bougadari, T, additional, Manraj, S S, additional, Bendahhou, K, additional, Fabowale, A, additional, Bradshaw, D, additional, Somdyala, N I M, additional, Kumcher, I, additional, Moreno, F, additional, Calabrano, G H, additional, Espinola, S B, additional, Carballo Quintero, B, additional, Fita, R, additional, Diumenjo, M C, additional, Laspada, W D, additional, Ibañez, S G, additional, Lima, C A, additional, De Souza, P C F, additional, Del Pino, K, additional, Laporte, C, additional, Curado, M P, additional, de Oliveira, J C, additional, Veneziano, C L A, additional, Veneziano, D B, additional, Latorre, M R D O, additional, Tanaka, L F, additional, Rebelo, M S, additional, Santos, M O, additional, Galaz, J C, additional, Aparicio Aravena, M, additional, Sanhueza Monsalve, J, additional, Herrmann, D A, additional, Vargas, S, additional, Herrera, V M, additional, Uribe, C J, additional, Bravo, L E, additional, Garcia, L S, additional, Arias-Ortiz, N E, additional, Morantes, D, additional, Jurado, D M, additional, Yépez Chamorro, M C, additional, Delgado, S, additional, Ramirez, M, additional, Galán Alvarez, Y H, additional, Torres, P, additional, Martínez-Reyes, F, additional, Jaramillo, L, additional, Quinto, R, additional, Castillo, J, additional, Mendoza, M, additional, Cueva, P, additional, Yépez, J G, additional, Bhakkan, B, additional, Deloumeaux, J, additional, Joachim, C, additional, Macni, J, additional, Carrillo, R, additional, Shalkow Klincovstein, J, additional, Rivera Gomez, R, additional, Poquioma, E, additional, Tortolero-Luna, G, additional, Zavala, D, additional, Alonso, R, additional, Barrios, E, additional, Eckstrand, A, additional, Nikiforuk, C, additional, Noonan, G, additional, Turner, D, additional, Kumar, E, additional, Zhang, B, additional, McCrate, F R, additional, Ryan, S, additional, MacIntyre, M, additional, Saint-Jacques, N, additional, Nishri, D E, additional, McClure, C A, additional, Vriends, K A, additional, Kozie, S, additional, Stuart-Panko, H, additional, Freeman, T, additional, George, J T, additional, Brockhouse, J T, additional, O'Brien, D K, additional, Holt, A, additional, Almon, L, additional, Kwong, S, additional, Morris, C, additional, Rycroft, R, additional, Mueller, L, additional, Phillips, C E, additional, Brown, H, additional, Cromartie, B, additional, Schwartz, A G, additional, Vigneau, F, additional, Levin, G M, additional, Wohler, B, additional, Bayakly, R, additional, Ward, K C, additional, Gomez, S L, additional, McKinley, M, additional, Cress, R, additional, Green, M D, additional, Miyagi, K, additional, Ruppert, L P, additional, Lynch, C F, additional, Huang, B, additional, Tucker, T C, additional, Deapen, D, additional, Liu, L, additional, Hsieh, M C, additional, Wu, X C, additional, Schwenn, M, additional, Gershman, S T, additional, Knowlton, R C, additional, Alverson, G, additional, Copeland, G E, additional, Bushhouse, S, additional, Rogers, D B, additional, Jackson-Thompson, J, additional, Lemons, D, additional, Zimmerman, H J, additional, Hood, M, additional, Roberts-Johnson, J, additional, Rees, J R, additional, Riddle, B, additional, Pawlish, K S, additional, Stroup, A, additional, Key, C, additional, Wiggins, C, additional, Kahn, A R, additional, Schymura, M J, additional, Radhakrishnan, S, additional, Rao, C, additional, Giljahn, L K, additional, Slocumb, R M, additional, Espinoza, R E, additional, Khan, F, additional, Aird, K G, additional, Beran, T, additional, Rubertone, J J, additional, Slack, S J, additional, Garcia, L, additional, Rousseau, D L, additional, Janes, T A, additional, Schwartz, S M, additional, Bolick, S W, additional, Hurley, D M, additional, Whiteside, M A, additional, Miller-Gianturco, P, additional, Williams, M A, additional, Herget, K, additional, Sweeney, C, additional, Johnson, A T, additional, Keitheri Cheteri, M B, additional, Migliore Santiago, P, additional, Blankenship, S E, additional, Farley, S, additional, Borchers, R, additional, Malicki, R, additional, Espinoza, J R, additional, Grandpre, J, additional, Wilson, R, additional, Edwards, B K, additional, Mariotto, A, additional, Lei, Y, additional, Wang, N, additional, Chen, J S, additional, Zhou, Y, additional, He, Y T, additional, Song, G H, additional, Gu, X P, additional, Mei, D, additional, Mu, H J, additional, Ge, H M, additional, Wu, T H, additional, Li, Y Y, additional, Zhao, D L, additional, Jin, F, additional, Zhang, J H, additional, Zhu, F D, additional, Junhua, Q, additional, Yang, Y L, additional, Jiang, C X, additional, Biao, W, additional, Wang, J, additional, Li, Q L, additional, Yi, H, additional, Zhou, X, additional, Dong, J, additional, Li, W, additional, Fu, F X, additional, Liu, S Z, additional, Chen, J G, additional, Zhu, J, additional, Li, Y H, additional, Lu, Y Q, additional, Fan, M, additional, Huang, S Q, additional, Guo, G P, additional, Zhaolai, H, additional, Wei, K, additional, Zeng, H, additional, Demetriou, A V, additional, Mang, W K, additional, Ngan, K C, additional, Kataki, A C, additional, Krishnatreya, M, additional, Jayalekshmi, P A, additional, Sebastian, P, additional, Nandakumar, A, additional, Malekzadeh, R, additional, Roshandel, G, additional, Keinan-Boker, L, additional, Silverman, B G, additional, Ito, H, additional, Nakagawa, H, additional, Sato, M, additional, Tobori, F, additional, Nakata, I, additional, Teramoto, N, additional, Hattori, M, additional, Kaizaki, Y, additional, Moki, F, additional, Sugiyama, H, additional, Utada, M, additional, Nishimura, M, additional, Yoshida, K, additional, Kurosawa, K, additional, Nemoto, Y, additional, Narimatsu, H, additional, Sakaguchi, M, additional, Kanemura, S, additional, Naito, M, additional, Narisawa, R, additional, Miyashiro, I, additional, Nakata, K, additional, Sato, S, additional, Yoshii, M, additional, Oki, I, additional, Fukushima, N, additional, Shibata, A, additional, Iwasa, K, additional, Ono, C, additional, Nimri, O, additional, Jung, K W, additional, Won, Y J, additional, Alawadhi, E, additional, Elbasmi, A, additional, Ab Manan, A, additional, Adam, F, additional, Sanjaajmats, E, additional, Tudev, U, additional, Ochir, C, additional, Al Khater, A M, additional, El Mistiri, M M, additional, Teo, Y Y, additional, Chiang, C J, additional, Lee, W C, additional, Buasom, R, additional, Sangrajrang, S, additional, Kamsa-ard, S, additional, Wiangnon, S, additional, Daoprasert, K, additional, Pongnikorn, D, additional, Leklob, A, additional, Sangkitipaiboon, S, additional, Geater, S L, additional, Sriplung, H, additional, Ceylan, O, additional, Kög, I, additional, Dirican, O, additional, Köse, T, additional, Gurbuz, T, additional, Karaşahin, F E, additional, Turhan, D, additional, Aktaş, U, additional, Halat, Y, additional, Yakut, C I, additional, Altinisik, M, additional, Cavusoglu, Y, additional, Türkköylü, A, additional, Üçüncü, N, additional, Hackl, M, additional, Zborovskaya, A A, additional, Aleinikova, O V, additional, Henau, K, additional, Van Eycken, L, additional, Valerianova, Z, additional, Yordanova, M R, additional, Šekerija, M, additional, Dušek, L, additional, Zvolský, M, additional, Storm, H, additional, Innos, K, additional, Mägi, M, additional, Malila, N, additional, Seppä, K, additional, Jégu, J, additional, Velten, M, additional, Cornet, E, additional, Troussard, X, additional, Bouvier, A M, additional, Guizard, A V, additional, Bouvier, V, additional, Launoy, G, additional, Arveux, P, additional, Maynadié, M, additional, Mounier, M, additional, Woronoff, A S, additional, Daoulas, M, additional, Robaszkiewicz, M, additional, Clavel, J, additional, Goujon, S, additional, Lacour, B, additional, Baldi, I, additional, Pouchieu, C, additional, Amadeo, B, additional, Coureau, G, additional, Orazio, S, additional, Preux, P M, additional, Rharbaoui, F, additional, Marrer, E, additional, Trétarre, B, additional, Colonna, M, additional, Delafosse, P, additional, Ligier, K, additional, Plouvier, S, additional, Cowppli-Bony, A, additional, Molinié, F, additional, Bara, S, additional, Ganry, O, additional, Lapôtre-Ledoux, B, additional, Grosclaude, P, additional, Bossard, N, additional, Uhry, Z, additional, Bray, F, additional, Piñeros, M, additional, Stabenow, R, additional, Wilsdorf-Köhler, H, additional, Eberle, A, additional, Luttmann, S, additional, Löhden, I, additional, Nennecke, A L, additional, Kieschke, J, additional, Sirri, E, additional, Emrich, K, additional, Zeissig, S R, additional, Holleczek, B, additional, Eisemann, N, additional, Katalinic, A, additional, Asquez, R A, additional, Kumar, V, additional, Petridou, E, additional, Ólafsdóttir, E J, additional, Tryggvadóttir, L, additional, Clough-Gorr, K, additional, Walsh, P M, additional, Sundseth, H, additional, Mazzoleni, G, additional, Vittadello, F, additional, Coviello, E, additional, Cuccaro, F, additional, Galasso, R, additional, Sampietro, G, additional, Giacomin, A, additional, Magoni, M, additional, Ardizzone, A, additional, D'Argenzio, A, additional, Castaing, M, additional, Grosso, G, additional, Lavecchia, A M, additional, Sutera Sardo, A, additional, Gola, G, additional, Gatti, L, additional, Ricci, P, additional, Ferretti, S, additional, Serraino, D, additional, Zucchetto, A, additional, Celesia, M V, additional, Filiberti, R A, additional, Pannozzo, F, additional, Melcarne, A, additional, Quarta, F, additional, Russo, A G, additional, Carrozzi, G, additional, Cirilli, C, additional, Cavalieri d'Oro, L, additional, Rognoni, M, additional, Fusco, M, additional, Vitale, M F, additional, Usala, M, additional, Cusimano, R, additional, Mazzucco, W, additional, Michiara, M, additional, Sgargi, P, additional, Boschetti, L, additional, Borciani, E, additional, Seghini, P, additional, Maule, M M, additional, Merletti, F, additional, Tumino, R, additional, Mancuso, P, additional, Vicentini, M, additional, Cassetti, T, additional, Sassatelli, R, additional, Falcini, F, additional, Giorgetti, S, additional, Caiazzo, A L, additional, Cavallo, R, additional, Cesaraccio, R, additional, Pirino, D R, additional, Contrino, M L, additional, Tisano, F, additional, Fanetti, A C, additional, Maspero, S, additional, Carone, S, additional, Mincuzzi, A, additional, Candela, G, additional, Scuderi, T, additional, Gentilini, M A, additional, Piffer, S, additional, Rosso, S, additional, Barchielli, A, additional, Caldarella, A, additional, Bianconi, F, additional, Stracci, F, additional, Contiero, P, additional, Tagliabue, G, additional, Rugge, M, additional, Zorzi, M, additional, Beggiato, S, additional, Brustolin, A, additional, Berrino, F, additional, Gatta, G, additional, Sant, M, additional, Buzzoni, C, additional, Mangone, L, additional, Capocaccia, R, additional, De Angelis, R, additional, Zanetti, R, additional, Maurina, A, additional, Pildava, S, additional, Lipunova, N, additional, Vincerževskiené, I, additional, Agius, D, additional, Calleja, N, additional, Siesling, S, additional, Larønningen, S, additional, Møller, B, additional, Dyzmann-Sroka, A, additional, Trojanowski, M, additional, Góźdź, S, additional, Mężyk, R, additional, Mierzwa, T, additional, Molong, L, additional, Rachtan, J, additional, Szewczyk, S, additional, Błaszczyk, J, additional, Kępska, K, additional, Kościańska, B, additional, Tarocińska, K, additional, Zwierko, M, additional, Drosik, K, additional, Maksimowicz, K M, additional, Purwin-Porowska, E, additional, Reca, E, additional, Wójcik-Tomaszewska, J, additional, Tukiendorf, A, additional, Grądalska-Lampart, M, additional, Radziszewska, A U, additional, Gos, A, additional, Talerczyk, M, additional, Wyborska, M, additional, Didkowska, J A, additional, Wojciechowska, U, additional, Bielska-Lasota, M, additional, Forjaz de Lacerda, G, additional, Rego, R A, additional, Bastos, J, additional, Silva, M A, additional, Antunes, L, additional, Laranja Pontes, J, additional, Mayer-da-Silva, A, additional, Miranda, A, additional, Blaga, L M, additional, Coza, D, additional, Gusenkova, L, additional, Lazarevich, O, additional, Prudnikova, O, additional, Vjushkov, D M, additional, Egorova, A G, additional, Orlov, A E, additional, Kudyakov, L A, additional, Pikalova, L V, additional, Adamcik, J, additional, Safaei Diba, C, additional, Primic-Žakelj, M, additional, Zadnik, V, additional, Larrañaga, N, additional, Lopez de Munain, A, additional, Herrera, A A, additional, Redondas, R, additional, Marcos-Gragera, R, additional, Vilardell Gil, M L, additional, Molina, E, additional, Sánchez Perez, M J, additional, Franch Sureda, P, additional, Ramos Montserrat, M, additional, Chirlaque, M D, additional, Navarro, C, additional, Ardanaz, E E, additional, Guevara, M M, additional, Fernández-Delgado, R, additional, Peris-Bonet, R, additional, Carulla, M, additional, Galceran, J, additional, Alberich, C, additional, Vicente-Raneda, M, additional, Khan, S, additional, Pettersson, D, additional, Dickman, P, additional, Avelina, I, additional, Staehelin, K, additional, Camey, B, additional, Bouchardy, C, additional, Schaffar, R, additional, Frick, H, additional, Herrmann, C, additional, Bulliard, J L, additional, Maspoli-Conconi, M, additional, Kuehni, C E, additional, Redmond, S M, additional, Bordoni, A, additional, Ortelli, L, additional, Chiolero, A, additional, Konzelmann, I, additional, Matthes, K L, additional, Rohrmann, S, additional, Broggio, J, additional, Rashbass, J, additional, Fitzpatrick, D, additional, Gavin, A, additional, Clark, D I, additional, Deas, A J, additional, Huws, D W, additional, White, C, additional, Montel, L, additional, Rachet, B, additional, Turculet, A D, additional, Stephens, R, additional, Chalker, E, additional, Phung, H, additional, Walton, R, additional, You, H, additional, Guthridge, S, additional, Johnson, F, additional, Gordon, P, additional, D'Onise, K, additional, Priest, K, additional, Stokes, B C, additional, Venn, A, additional, Farrugia, H, additional, Thursfield, V, additional, Dowling, J, additional, Currow, D, additional, Hendrix, J, additional, and Lewis, C, additional
- Published
- 2018
- Full Text
- View/download PDF
9. Second Malignancy Risk in Patients with Bronchopulmonary Carcinoids: Epidemiological Results from Italian Network of Cancer Registries
- Author
-
Lococo, Filippo, Galeone, Carla, Sacchettini, Claudio, Leuzzi, Giovanni, Cesario, Alfredo, Paci, Massimiliano, Mangone, Lucia, Autelitano, M., Mannino, S., Filiberti, R.A., Borciani, E., Buzzoni, C., Candela, G., D'oro, L. Cavalieri, Coviello, V., Caiazzo, A. L, Barchielli, A., Crocetti, E., Cusimano, R., Rugge, M., Falcini, F., Ferretti, S., Fusco, M., Gennaro, V., Giacomin, A., Gola, G., Stracci, F., Madeddu, A., Magoni, M., Mangone, L., Spagnoli, M., Maspero, S., Mazzoleni, G., Melcarne, A., Merletti, F., Michiara, M., Minerba, S., Pannozzo, F., Piffer, S., Quarta, F., Ricci, P., Russo, A., Sampietro, G., Sciacca, S., Sensi, F., Serraino, D., Sardo, A. Sutera, Tagliabue, G., Tisano, F., Traina, A., Tumino, R., Usala, M., Vitale, F., and Vitarelli, S.
- Abstract
Purpose This epidemiological study aimed to determine the prevalence and characteristics of second tumors (STs) in patients with bronchopulmonary carcinoids (BCs).Methods Data on neuroendocrine carcinomas (NECs) from the AIRTUM registry (1975-2011) were used for the analysis. Among 32,325 NECs, we focused our analysis on 3,205 patients (9.9%) affected by BCs. The overall ST number and incidence were calculated. The number of STs was compared with the expected cancer number in the healthy Italian population, and the standardized incidence ratio (SIR) and 95% confidence intervals were calculated.Results The male/female ratio was 1.5:1 and the mean age 61.7 years (range: 7-94). A total of 640 STs were observed (overall incidence: 20%): 198 tumors were metachronous, 23 synchronous, and 419 occurred before the diagnosis of BC. The most common STs were bladder tumors (12.2%) followed by breast tumors (11.1%). We observed a large number of thyroid tumors (SIR = 3.88), with a remarkably higher frequency of thyroid tumors being synchronously detected with BC in female patients (SIR = 61.39). In male patients there was an increased frequency of urinary system tumors, in particular metachronous tumors of the kidney and renal pelvis (SIR = 3.34) and synchronous tumors of the urinary bladder (SIR = 11.48).Conclusions A high frequency of STs is predictable in patients with BCs, with synchronous thyroid tumors being observed in women and kidney and urinary bladder tumors in men. However, these data should be interpreted with caution, considering that the diagnosis of such tumors often occurs as an incidental finding during investigations for other malignancies.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.